ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,363Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 944

$745K Total Retail Price of All Prescriptions

Rank: 54 out of 944

442 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 9,912 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 495 432 1 1
OMEPRAZOLE 416 336 2 4
LEVOTHYROXINE SODIUM 379 296 3 2
LISINOPRIL 368 329 4 3
ATORVASTATIN CALCIUM 313 301 5 13
WARFARIN SODIUM 308 306 6 7
CARVEDILOL 293 278 7 30
AMLODIPINE BESYLATE 273 273 8 5
HYDROCODONE-ACETAMINOPHEN 262 172 S3 9 10
PRAVASTATIN SODIUM 235 225 10 17
CRESTOR 224 210 11 28
FUROSEMIDE 220 187 12 6
SYNTHROID 209 181 13 82
LOSARTAN POTASSIUM 174 155 14 16
PANTOPRAZOLE SODIUM 158 134 15 34
METFORMIN HCL ER 141 126 16 49
METOPROLOL SUCCINATE 137 125 17 14
POTASSIUM CHLORIDE 137 113 17 15
METFORMIN HCL 132 112 19 12
GLIMEPIRIDE 129 129 20 47
NEXIUM 125 87 21 53
INDAPAMIDE 125 121 21 130
BENAZEPRIL HCL 117 117 23 66
CITALOPRAM HBR 116 111 24 19
ZETIA 109 102 25 59
CLOPIDOGREL 109 102 25 36
FENOFIBRATE 106 106 27 58
TAMSULOSIN HCL 98 86 28 27
SPIRONOLACTONE 96 79 29 44
HYDROCHLOROTHIAZIDE 95 95 30 9
ZOLPIDEM TARTRATE 93 81 31 25
DONEPEZIL HCL 91 91 32 24
NIASPAN 89 84 33 76
TRAMADOL HCL 79 67 34 21
ALLOPURINOL 78 58 35 22
PLAVIX 75 71 36 55
DIOVAN 74 74 37 38
DIGOXIN 71 71 38 39
SERTRALINE HCL 71 68 38 23
NAMENDA 70 70 40 37
ADVAIR DISKUS 69 37 41 31
ATENOLOL 68 68 42 11
METOPROLOL TARTRATE 68 68 42 8
CELEBREX 64 64 44 110
DOXAZOSIN MESYLATE 62 42 45 60
TRIAMTERENE-HCTZ 62 62 45 33
LIPITOR 58 53 47 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 44 48 29
POLYETHYLENE GLYCOL 3350 56 49 49 41
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 49 54
LANTUS 56 48 49 46
ESCITALOPRAM OXALATE 56 51 49 98
ALENDRONATE SODIUM 55 55 53 20
FLUTICASONE PROPIONATE 55 46 53 40
ISOSORBIDE MONONITRATE ER 53 53 55 52
GABAPENTIN 52 45 56 18
VENLAFAXINE HCL ER 51 38 57 84
AMLODIPINE BESYLATE-BENAZEPRIL 51 47 57 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.